Neither BPC-157 nor TB-500/thymosin beta-4 is approved by the FDA for any human therapeutic use , and neither is an approved treatment for any neurological condition
F., Horng A., Niethammer T., Pagenstert I., Sievers B., Jansson V., et al
Dosing for back pain: Standard protocols involve 250-500mcg twice daily via subcutaneous injection
(2009) cMyc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism, Nature , 458 , 762-765, doi: Altman, B
Glutathione & Detoxification: The Methylation Connection
According to a study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) titled Understanding the Dangers of Alcohol Overdose, 2023, early medical intervention reduces overdose fatality by up to 40%